Riskpilot← Back to searchSign inGet full accessAlimenta Medical AB
ABActiveOrg 5565458766Virdings Allé 32 BPatent brokering and marketing service activities · NACE 7491Est. 19970 employees
Revenue 2025
SEK 0
EBITDA margin
—
-138% vs 2024
Equity ratio
94.6%
Financial strength
Net profit 2025
SEK -10K
-138% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | -138% |
| Net profit | SEK -10K | -138% |
| Total assets | SEK 3,3M | +0% |
| Equity | SEK 3,2M | +0% |
| Employees | 0 | — |
Legal name
Alimenta Medical AB
Org number
5565458766
Legal form
Aktiebolag
NACE code
7491 · Patent brokering and marketing service activities
Founded
3 september 1997
Share capital
SEK 3 642 240
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling och utvärdering av produkter för diagnostik av födoämnesöverkänslighet samt därmed förenlig verksamhet.
Address
Virdings Allé 32 B
Phone
+46850566363
Email
bengt.fellstrom@medsci.uu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −22 | −20 | −15 | −4 | −10 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −22 | −20 | −15 | −4 | −10 |
| Net financials | −3 | −1 | 0 | 0 | 0 |
| Profit before tax | −25 | −20 | −15 | −4 | −10 |
| Tax | −0 | — | — | — | — |
| Net profit | −25 | −20 | −15 | −4 | −10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 332 | 3 334 | 3 336 | 3 337 | 3 338 |
| Equity | 2 921 | 2 901 | 2 886 | 3 167 | 3 157 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 410 | 434 | 450 | 170 | 181 |
| Total debt | 410 | 434 | 450 | 170 | 181 |
EBITDA margin
-998800.0%
This company
15.8%
Market median
-6321619% vs market
20212025
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20212025
Net profit margin
-998700.0%
This company
8.1%
Market median
-12329730% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
UP | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alimenta Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Peter Sigvard Fäldt | Audit | 0 companies |
| Per Sören Wendelboe Venge | Board of Directors | 0 companies |
| Bengt Christer Fellström | Chairman | 0 companies |
| Knut Terje Smerud | Board of Directors | 0 companies |